The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Arrest Oral Suspension

2.50/3.75 percent weight/volume Oral suspension

Ancare Ireland Ltd.VPA10915/003/001

Main Information

Trade NameArrest Oral Suspension
Active SubstancesFenbendazole
Levamisole hydrochloride
Strength2.50/3.75 percent weight/volume
Dosage FormOral suspension
Licence HolderAncare Ireland Ltd.
Licence NumberVPA10915/003/001

Group Information

ATC CodeQP52AC13 fenbendazole
QP52AE01 levamisole
Therapeutic ClassEndoparasiticide


Licence Issued26/01/2001
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back